Personnel
Dr. Paul Coussens joins HepaLife's scientific advisory board
Published in Virus Weekly, September 12th, 2006
"Dr. Coussens' in-depth knowledge of molecular virology will be a great asset to us in the development of our new cell-culture based vaccine to protect against the spread of influenza viruses, including the highly lethal H5N1 avian flu virus," stated Harmel S. Rayat, president and CEO of HepaLife Technologies.
"Due to the threat of the deadly H5N1 virus being spread by migratory birds, which are now nesting in Alaska and Canada and will...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Virus Weekly
Source: Virus Weekly (2006-09-12)
More Articles from Virus Weekly
- Chemotherapy
Combined chemotherapy-virotherapy inhibits multidrug-resistant phenotype - Foamy Virus Pathogenesis
Foamy virus capsids assemble at a pericentriolar site in the cytoplasm - Herpes Simplex Virus
Bacterial artificial chromosomes containing HSV-1 strains 17 and KOS have been constructed - Respiratory Syncytial Virus Drug Development
Respiratory syncytial virus inhibited by nucleocapsid gene targeted DNAzyme - Stem Cell Transplantation
Adenovirus-specific CD8+ cytotoxic T cells detected in blood of healthy adults - Atherosclerosis
Rapid arterial wall lipid deposition facilitated by lipoprotein lipase expression - More from this issue of Virus Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
